-

NYSE to Commence Delisting Proceedings Against Babylon Holdings Limited (BBLN)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A ordinary shares of Babylon Holdings Limited (the “Company”) — ticker symbol BBLN — from the NYSE. Trading in the Company’s Class A ordinary shares will be suspended immediately.

On June 22, 2023, NYSE Regulation notified the Company of noncompliance with the continued listing standards in Sections 802.01B and 802.01C of the NYSE Listed Company Manual. On June 28, 2023, the Company informed the NYSE and made public disclosure that it did not intend to submit a business plan demonstrating its ability to return to compliance with continued listing standards within 18 months of the notice from the Exchange and did not have an intention to cure the price noncompliance within six months of the notice from the Exchange, as required by Sections 802.02 and 802.01C of the NYSE Listed Company Manual, respectively. NYSE Regulation has determined that the Company is no longer suitable for listing since the Company does not intend to undertake actions to cure its deficiencies and return to compliance with the continued listing standards in Sections 802.01B and 802.01C of the NYSE Listed Company Manual.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Class A ordinary shares upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contact:
Media
press@babylonhealth.com

Investors
investors@babylonhealth.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contact:
Media
press@babylonhealth.com

Investors
investors@babylonhealth.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE Group Consolidated Short Interest Report

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of December 15, 2025. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 12/15/2025 NYSE 16,401,052,680 16,170,141,102 2,876 2,555 12/15/2025 NYSE ARCA 2,248,888,701 2,169,649,765 2,519 1,703 12/15/2025 NYSE AMERICAN 818,416,336 772,363,508 303...

NYSE to Commence Delisting Proceedings with Respect to Warrants of UWM Holdings Corporation (UWMC WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol UWMC WS — each warrant exercisable for one share of Class A common stock at an exercise price of $11.50 with an expiration date of January 21, 2026 of UWM Holdings Corporation (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Tr...

NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol RBOT WS — thirty (30) whole warrants are exercisable to purchase one share of Class A common stock of Vicarious Surgical Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company’s Class A common stock — tick...
Back to Newsroom